Professor of Medicine, Boston University
Nephrology
Dr. David J. Salant, MD
|
|
Give Review
David Salant is an expert in the field of Nephrology. He has 5 awards "America's Top Doctors", "Boston Magazine", "Boston Herald", "Elected Member" and "Super Doctor". David Salant is a published doctor. He has 100 publications published. The most current publication "Treatment of acute interstitial nephritis." He accepts Medicare.
Publications
- Thrombospondin Type-1 Domain-Containing 7A in Idiopathic Membranous Nephropathy.
- Glomerular Disease: Looking beyond Pathology.
- Genetic Variants in Membranous Nephropathy: Perhaps a Perfect Storm Rather than a Straightforward Conformeropathy?
- Inhibitory Effects of Robo2 on Nephrin: A Crosstalk between Positive and Negative Signals Regulating Podocyte Structure.
- IgG4-Related Disease Is Not Associated with Antibody to the Phospholipase A2 Receptor.
- Crk1/2-dependent signaling is necessary for podocyte foot process spreading in mouse models of glomerular Disease.
- Rituximab-Induced Depletion of Anti-PLA2R Autoantibodies Predicts Response in Membranous Nephropathy.
- Membranous Nephropathy Associated With IgG4-Related Disease.
- Anti-phospholipase A2 receptor antibody in membranous Nephropathy.
- The fate of Notch-deficient nephrogenic progenitor cells during metanephric Kidney development.
- Anti-Phospholipase A2 Receptor Antibodies Correlate With Clinical Status in Idiopathic Membranous Nephropathy.
- Epidermal growth factor receptor promotes glomerular injury and renal failure in rapidly progressive crescentic Glomerulonephritis.
- Noninvasive assessment of antenatal Hydronephrosis in mice reveals a critical role for robo2 in maintaining anti-reflux mechanism.
- Targeting complement C5 in atypical hemolytic uremic Syndrome.
- Goodpasture's Disease--new secrets revealed.
- Blockade of the kinin B1 receptor ameloriates Glomerulonephritis.
- Methylation determines fibroblast activation and fibrogenesis in the Kidney.
- Membranous Nephropathy: recent travels and new roads ahead.
- M-type phospholipase A2 receptor as target antigen in idiopathic membranous Nephropathy.
- Treatment of membranous lupus Nephritis: where are we now?
- Glomerular and tubulointerstitial Diseases.
- A case of atypical light chain deposition Disease--diagnosis and treatment.
- SRY-related HMG box 9 regulates the expression of Col4a2 through transactivating its enhancer element in mesangial cells.
- Glomerular Disease workshop.
- Experimental membranous Nephropathy redux.
- Rapamycin ameliorates proteinuria-associated tubulointerstitial inflammation and fibrosis in experimental membranous Nephropathy.
- Nephrin and podocin dissociate at the onset of proteinuria in experimental membranous Nephropathy.
- Membranoproliferative Glomerulonephritis type II (dense deposit disease): an update.
- Anti-C1q autoantibodies deposit in glomeruli but are only pathogenic in combination With glomerular C1q-containing immune complexes.
- Respective roles of decay-accelerating factor and CD59 in circumventing glomerular injury in Acute nephrotoxic serum nephritis.
- Complement mediates nephrin redistribution and actin dissociation in experimental membranous Nephropathy.
- An outline of essential topics in glomerular pathophysiology, diagnosis, and treatment for nephrology trainees.
- Essential role of Gas6 for glomerular injury in nephrotoxic Nephritis.
- Decay-accelerating factor confers protection against complement-mediated podocyte injury in Acute nephrotoxic nephritis.
- IL-15, a survival factor for Kidney epithelial cells, counteracts apoptosis and inflammation during nephritis.
- Nephrin dissociates from actin, and its expression is reduced in early experimental membranous Nephropathy.
- Podocyte slit-diaphragm protein nephrin is linked to the actin cytoskeleton.
- Factors influencing glomerular and tubulointerstitial patterns of injury in SLE.
- Studies of experimental membranous Nephropathy.
- Comparative study of in situ Immune deposit formation in active and passive Heymann nephritis.
- Mediation of proteinuria in membranous Nephropathy due to a planted glomerular antigen.
- Role of the terminal complement pathway in experimental membranous Nephropathy in the rabbit.
- Effect of antibody charge and concentration on deposition of antibody to glomerular basement membrane.
- In situ Immune complex formation and glomerular injury.
- Specific uptake of Heymann's nephritic Kidney eluate by rat Kidney: studies in vivo and in isolated perfused Kidneys.
- Altered glomerular permeability induced by F(ab'')2 and Fab'' antibodies to rat Renal tubular epithelial antigen.
- Experimental membranous Glomerulonephritis in rats. Quantitative studies of glomerular immune deposit formation in isolated glomeruli and whole animals.
- A new role for complement in experimental membranous Nephropathy in rats.
- Developmental expression of the nephritogenic antigen of monoclonal antibody 5-1-6.
- The effect of VH residues 6 and 23 on IgG3 cryoprecipitation and glomerular deposition.
- In search of the elusive membranous Nephropathy antigen.
- Management of glomerular Diseases of primary and secondary origin.
- The structural biology of glomerular epithelial cells in proteinuric Diseases.
- Inhibition of histone deacetylase activates side population cells in Kidney and partially reverses chronic renal injury.
- Lysophosphatidic acid and Renal fibrosis.
- New approaches to the treatment of dense deposit Disease.
- Intravenous methylprednisolone or plasma exchange for adjunctive therapy of severe Renal vasculitis?
- Role of nephrin in proteinuric renal Diseases.
- The nephritogenic Immune response.
- Expression of type I collagen mRNA in glomeruli of rats With passive Heymann nephritis.
- Fish oil has protective and therapeutic effects on proteinuria in passive Heymann Nephritis.
- Fish oil ameliorates Renal injury and hyperlipidemia in the Milan normotensive rat model of focal glomerulosclerosis.
- Characterization of a rat glomerular visceral epithelial cell line.
- Effects of omega-3 fatty acids on complement-mediated glomerular epithelial cell injury.
- RANTES and monocyte chemoattractant protein-1 (MCP-1) play an important role in the inflammatory phase of crescentic Nephritis, but only MCP-1 is involved in crescent ...
- Nephrology core curriculum. The American Society of Nephrology and the American Society of Nephrology Training Program Directors Committee.
- Acute renal failure due to lymphomatous infiltration of the kidneys.
- Intercellular adhesion molecule-1 deficiency prolongs survival and protects against the development of pulmonary inflammation during murine lupus.
- Glomerular epithelial cell products stimulate mesangial cell proliferation in culture.
- Role of MCP-1 and RANTES in inflammation and progression to fibrosis during murine crescentic Nephritis.
- Slit diaphragm-reactive nephritogenic MAb 5-1-6 alters expression of ZO-1 in rat podocytes.
- Blockade of antibody-induced Glomerulonephritis with Crry-Ig, a soluble murine complement inhibitor.
- Renal immunology and pathology.
- Augmented expression of glomerular basement membrane specific type IV collagen isoforms (alpha3-alpha5) in experimental membranous Nephropathy.
- Visceral glomerular epithelial cell DNA synthesis in experimental and human membranous Disease.
- Inhibition of complement regulation is key to the pathogenesis of active Heymann Nephritis.
- Acceleration of lpr lymphoproliferative and autoimmune Disease by transgenic protein kinase CK2 alpha.
- Acute nephrotoxic serum nephritis in complement knockout mice: relative roles of the classical and alternate pathways in neutrophil recruitment and proteinuria.
- Treatment of Acute interstitial nephritis.
- ANCA: fuel for the fire or the spark that ignites the flame?
- Complement-mediated injury reversibly disrupts glomerular epithelial cell actin microfilaments and focal adhesions.
- Lack of chemokine receptor CCR1 enhances Th1 Responses and glomerular injury during nephrotoxic nephritis.
- Nephritogenic mAb 5-1-6 is directed at the extracellular domain of rat nephrin.
- Cloning of rat nephrin: expression in developing glomeruli and in proteinuric states.
- Aminopeptidase A: a nephritogenic target antigen of nephrotoxic serum.
- Targeted deletion of CX(3)CR1 reveals a role for fractalkine in cardiac allograft rejection.
- Evaluation of 125I-DNA for detecting anti-DNA antibodies in the diagnosis of systemic lupus erythematosus.
- Experimental Glomerulonephritis in the isolated perfused rat kidney.
- Determinants of glomerular localization of subepithelial Immune deposits: effects of altered antigen to antibody ratio, steroids, vasoactive amine antagonists, and ami...
- The effects of aminonucleoside of puromycin and nephrotoxic serum on subepithelial Immune-deposit formation in passive Heymann nephritis.
- Antithrombin functional activity after a fatty meal in normal subjects, familial hyperlipidemia, and Nephrotic syndrome.
- Analgesic abuse and microvascular changes.
- Dermal micro-angiopathy in patients With analgesic nephropathy.
- Polymorphonuclear leucocyte function in chronic renal Failure and after renal transplantation.
- Lymphocoeles in Renal homograft recipients.
- Cross-matching assays of cell-mediated immunity for transplant patients.
- Coagulation studies in long-term survivors after Renal allograft transplantation.
- Pregnancy in Renal transplant recipients.
- Hyperlipidaemia in Renal transplant patients.
Schools
University Of The Witwatersrand Faculty Of Health Sciences
Procedures Preformed
- Hemodialysis
Conditions Treated
- Acidosis
- Acute GlomeruloNephritis
- Acute Kidney Failure
- Amyloidosis
- View All
Doctors Specialties
- Nephrology
Accepted Insurances
Awards
- America's Top Doctors
- Boston Magazine
- Boston Herald
- Elected Member
- Super Doctor
Education
-
Boston University Medical Center -
University of the Witwatersrand
Hospital
-
Boston Medical Center
Drug Facts
| NPI NUMBER | 1083685093 | |
| NPPES Provider LastName | SALANT | |
| NPPES Provider FirstName | DAVID | |
| NPPES Provider ZIPCode | 021182526 | |
| NPPES Provider State | MA | |
| Specialty Description | Nephrology | |
| Total Claim Count | 145.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1083685093 |
| Last Name Of The Provider | SALANT |
| First Name Of The Provider | DAVID |
| View All |
Similar Doctors
|
|
Dr. Brian Y. Lee, MD |
|
|
Dr. Nina T. Rubin, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Gearoid M. McMahon, MB
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kenneth M. Ralto, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Adam M. Segal, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jose C. Da Silva, MD |
|
|
Dr. Adam Segal, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Samir M. Parikh, MD |
|
|
Dr. John A. D'Elia, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Smita Padala, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jasvinder S. Bhatia, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shveta Motwani, MD |